IOVA
Iovance Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.79
+1.03%Leverage
- Debt / equity
- 0.06x
- Net debt / equity
- -0.09x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.18x
- Net debt / EBITDA
- 0.25x
Liquidity & coverage
- Current ratio
- 4.35x
- Quick ratio
- 3.82x
- Cash ratio
- 2.79x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $357.4M
Cash & dividend
- FCF / debt
- -6.44x
- Cash flow / debt
- -5.74x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026